Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2021 Earnings Conference Call March 2, 2022 4:30 PM ET Company Participants Philip Taylor - IR Drew Spaventa - Founder and CEO Dalen Meeter - Head of Finance Dave Daly - President and COO Eli Glezer - Founder and Chief Scientific Officer Conference Call Participants Tycho Peterson - JPMorgan Matt Sykes - Goldman Sachs John Sourbeer - UBS Dan Brennan - Cowen Operator Good day, and thank you for standing by. Welcome to the Singular Genomics Fourth Quarter Resul ...

S I N G G U L A R GENOMICS JP Morgan 40th Annual Healthcare Conference 2022 Drew Spaventa | Chairman and CEO FORWARD-LOOKING STATEMENTS All statements in this presentation and the associated discussion that are not statements of historical facts constitute forwardlooking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding: (i) our ability to successfully complete the development of our G4 and ...

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Philip Taylor - Investor Relations Drew Spaventa - Founder & Chief Executive Officer Dalen Meeter - Head of Finance Dave Daly - President & Chief Operating Officer Eli Glezer - Founder & Chief Scientific Officer Conference Call Participants Michael Ryskin - Bank of America Tom Stevens - Cowen John Sourbeer - UBS Operator Greetings and welcome to the Singular Genomics Third Quarter ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-40443 SINGULAR GENOMICS SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware 81-2948451 (Sta ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-40443 SINGULAR GENOMICS SYSTEMS, INC. (Exact name of Registrant as specified in its charter) Delaware 81-2948451 (State or ...